A significant volume of high-end laboratory equipment from a recently operational biopharma research environment is being offered through a major online auction following the closure of the Medigene GmbH R&D facility in Planegg near Munich, Germany. The sale presents a rare opportunity for research institutions, biotechnology and pharmaceutical companies, laboratories, and equipment resellers to acquire premium scientific assets originating directly from an active research setting.

With more than 1,000 lots available, this comprehensive laboratory liquidation covers a wide spectrum of advanced technologies supporting genomics, cell biology, sequencing, imaging, and automated laboratory workflows.

Unlike surplus or warehouse equipment, the instruments available in this auction come from a functioning research infrastructure, making them particularly attractive for organizations seeking reliable, high-performance systems ready for integration into existing lab environments.

Advanced Genomics and Sequencing Technologies

The auction features an exceptional selection of genomics equipment designed to support high-throughput research and precision workflows.

Highlights include:

• Illumina Next-Generation Sequencing (NGS) systems, recognized globally as a gold standard for scalable genomic analysis
• Chromium Controller platforms enabling advanced single-cell genomics applications
• Supporting technology for library preparation and genomics workflows

Access to equipment of this caliber allows laboratories to expand sequencing capacity while significantly reducing capital expenditure compared to purchasing new systems.

For growing biotech companies and research facilities, opportunities to acquire pre-owned Illumina platforms through a structured online auction remain relatively rare in the European market.

Cell Analysis, Sorting, and Functional Research Systems

Further strengthening the scope of the sale is a robust portfolio of cell analysis technologies essential for modern biomedical research.

Featured assets include:

• IsoPlexis single-cell functional analyzers
• Sony and BD FACS Aria cell sorting systems
• Miltenyi Biotec MACSQuant 10 flow cytometer

These technologies play a critical role in immunology, oncology, and translational research, supporting complex analytical workflows and enabling high-resolution cellular insights.

The availability of multiple systems within one event offers buyers a strategic advantage — whether upgrading existing capabilities or building new research infrastructure.

Automation, Imaging, and Core Laboratory Infrastructure

Beyond specialized genomic and cell analysis tools, the Medigene laboratory auction provides access to essential automation and imaging technologies that form the backbone of efficient lab operations.

Key equipment includes:

• Tecan automated liquid handling systems for reproducible, high-throughput workflows
• Sartorius Incucyte live-cell imaging systems
• Zeiss fluorescence microscopes
• Imaging and scanning systems for biological samples

Complementing these are laboratory incubators from Thermo Scientific, refrigeration and freezer units from PHCBI, high-performance centrifuges by Eppendorf, and extensive supporting equipment for sample preparation, microscopy, and research workflows.

Together, these assets create a compelling opportunity for buyers seeking both specialized instrumentation and foundational laboratory infrastructure within a single auction.

Equipment from an Operational Research Environment

One of the defining characteristics of this sale is the origin of the equipment.

Assets sourced directly from a recently active biopharma facility typically demonstrate:

• consistent maintenance standards
• professional operating conditions
• integration within regulated research workflows

For buyers, this often translates into lower deployment risk and faster implementation compared to equipment of unknown provenance.

In today’s secondary laboratory equipment market, traceability and operational history have become key purchasing considerations — making this liquidation particularly noteworthy.

Strategic Opportunity for the European Laboratory Market

Demand for high-quality used laboratory equipment continues to grow as organizations seek flexible ways to scale research capabilities while managing budgets.

Auctions of this scale — especially those featuring advanced genomics and sequencing platforms — remain relatively uncommon, positioning the Medigene sale as a strategically relevant event for the European life sciences sector.

Whether expanding sequencing capacity, enhancing automation, or upgrading imaging capabilities, buyers will find a breadth of technologies aligned with modern research requirements.

Auction Details and Registration

The two-day online auction concludes on 24 & 25 February, with bidding accessible globally.

Early registration is strongly recommended to ensure timely bidding approval and full access to the catalogue, detailed lot descriptions, and sale updates.

👉 Register now to participate in this major biopharma laboratory liquidation and secure high-value research equipment from a trusted operational source.